| TABLE I - Demographic and infertility characteristics of patients receiving 150 IU or 200 IU follitropin-β regimens | |||
| Characteristics | Group A (150 IU r-FSH) n=40 | Group B (200 IU r-FSH) n=36 | Statistical significance |
|---|---|---|---|
| Age (years) |
31.4±2.8 | 31.7±2.8 | NS |
| Duration of infertility (years) |
6.1±2.5 | 6.7±3.3 | NS |
| Primary infertility | (29/40) 73% | (27/36) 75% | NS |
| Secondary infertility | (11/40) 27% | (9/36) 25.0% | NS |
| Tubal factor | (19/40) 47.5% | (21/36) 58% | NS |
| Male factor | (11/40) 27.5% | (9/36) 25% | NS |
| Endometriosis | (3/40) 7.5% | (2/36) 6% | NS |
| Unexplained infertility | (7/40) 17.5% | (4/36) 11% | NS |
| FIV cycles | 25/39 (64%) | 25/33 (75%) | NS |
| ICSI cycles | 14/39 (35.8%) | 11/33 (33.3%) | NS |
Note: *Values are means ± SD; NS = not significant.